With advances in Whole Genome Sequencing (WGS) technology, more advanced statistical methods for testing genetic association with rare variants are being developed.
INTRODUCTION METHODS
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Generalized Linear Mixed Models (GLMMs) 9 We formulate the SMMAT tests (SMMAT-B, SMMAT-S, SMMAT-O and SMMAT-E) 10 from the same GLMM 11 ( ) = + + , (Equation 1) where (•) is a monotonic "link" function that connects the mean of phenotype , denoted 12 by = ( | , , ) , for subject of samples, to the covariate row vector , 13 the genotype row vector for genetic variants in a set, and the random effects that 14 accounts for population structure and relatedness. The phenotypes follow a distribution 15 in the exponential family. For continuous traits, we usually assume follow a normal 16 distribution and use an identity link function; for binary traits, we assume follow a 17 Bernoulli distribution and use a logit link function. In Equation 1, is a × 1 vector of 18 fixed covariate effects including an intercept, and the genotype effects are assumed to be 19 a × 1 vector whose distribution has mean 0 and covariance 2 , where = 20 { } is a pre-specified × matrix assigning weights to each variant, is a variance 21 component parameter, and is a column vector of length with all elements 1. We assume that ~ ( , ∑ =1 ) is an × 1 vector of random effects , with variance 1 component parameters and known × relatedness matrices . We allow for 2 multiple random effects to account for complex sampling designs such as hierarchical 3 designs and shared environmental effects. } for binary traits in logistic mixed models (where the dispersion parameter 1 is known to be 1).
3
On the other hand, if we test 0 : = 0 under the assumption 0 = 0 , a variance 4 component score-type test SMMAT-S can be constructed as
Under 0 : = 0, asymptotically follows ∑
1, 2 =1
, where 1, 2 are independent chi-7 square distributions with 1 df, and are the eigenvalues of =̂. Appendix that can be approximated by
Therefore, under 0 : = 0, asymptotically approximately follows ∑ Fisher's method with a chi-square distribution with 4 df as = ( 4 2 > −2 log( )). and their covariance 19 matrix =̂ are computed for each variant set in each study, we can reconstruct
For each variant set, let = 1, 2, ⋯ , be the index of studies, and be the single- SMMAT-E. When combining studies with very different sample characteristics, testing the 10 "strong" null hypothesis 26 that genetic effects in all studies are 0 is sometimes desired. In 11 the general case, we may choose to group studies that are similar and test if the summary 12 genetic effects in all groups are 0, for example, in the meta-analysis of multi-ethnic samples. We performed coalescent simulations to generate sequence data with 100 genetic variants 6 in each set, and 10,000 independent sets for 8,000 individuals from a 20 × 20 grid of 7 spatially continuous populations with migration rate between adjacent cells = 10 8 ( Figure 1A ). Within each cell, we paired 20 individuals into 10 families and simulated 2 9 children for each family using gene dropping, 27 and in total we had 4,000 families and For binary traits, in each simulation replicate, we simulated the phenotype for 9 individual in family under the null hypothesis of no genetic association from 10 log (
where 0 was chosen such that the disease prevalence was 0.01 in all populations, and the 11 familial random effects were simulated in the same way as for continuous traits. Then 12 we randomly sampled 2,500 cases and 1,000 controls from the 10 × 10 grid in the top left 13 (Population 1), and 2,500 cases and 4,000 controls from the rest of the map (Population 2) 14 to form a hypothetical study with balanced cases and controls in combined populations.
15
Therefore, there was confounding by population structure resulting from unequal sampling, 16 even though the disease prevalence was the same. We removed the family identifier, 17 compared SMMAT-B, SMMAT-S, SMMAT-O and SMMAT-E in analyzing 10,000 18 independent variant sets based on a logistic mixed model using our GMMAT package, 19 similarly as described above, and repeated this 4,000 times to get p values combined from 20 40 million independent genetic variant sets for each test.
21
Type I error in meta-analysis 1 We also conducted simulation studies in the meta-analysis context to evaluate the type I 2 error rates. We considered 4 scenarios: unrelated individuals, without confounding by 3 population structure (Scenario A studies); related individuals, with confounding by 4 population structure (Scenario B studies); unrelated individuals, with confounding by 5 population structure (Scenario C studies); and related individuals, without confounding by 6 population structure (Scenario D studies). For Scenario A studies, we simulated 16 unrelated individuals in each cell from the 10 × 9 10 grid in the top left of the map ( Figure 1B ). For continuous traits, we simulated the 10 phenotype from Equation 4, with 1 = 0 and = 0, and randomly sampled 1,000 11 individuals. For binary traits, we simulated from Equation 6, with = 0 , and 12 randomly sampled 500 cases and 500 controls. In each simulation replicate, we simulated 3 studies from each scenario, totaling 12 studies 17 with a combined sample size of 12,000 (6,000 cases and 6,000 controls for binary traits).
18
We compared SMMAT-B, SMMAT-S, SMMAT-O and SMMAT-E using two meta-19 analysis strategies: all studies in the same group, and Scenario A, B, C, D studies in 4 20 separate groups. In the latter case, 3 studies from the same scenario were grouped in the 21 same partition with shared genetic effects, while studies from different scenarios were allowed to have heterogeneous genetic effects. We repeated 4,000 simulation replicates to 1 get p values from 40 million independent genetic variant sets. For binary traits, we simulated the phenotype for individual in family from 21 log ( ( = 1) 1 − ( = 1) ) = 0 + ∑ + ,
where 0 was chosen such that the disease prevalence was 0.01 in all populations, was 1 the centered genotype for causal variant of individual in family , the causal effect size 2 was | | = |log 10 | for variant with , where the constant was set to 0.3, 0.2 3 and 0.1 when the proportion of causal variants was 10%, 20% and 50%, the familial random 4 effects were simulated using Equation 5. We randomly sampled 35% individuals (with 5 25% cases and 10% controls out of the total sample size) from Population 1, and 65% 6 individuals (with 25% cases and 40% controls out of the total sample size) from Population 7 2 to form a hypothetical study with balanced cases and controls in combined populations. For both continuous and binary traits, we varied the total sample size from 2,000, 5,000 to study participants. Amish, CFS, FHS, JHS, and SAFS are family-based studies with 1 differing degrees of relatedness. The total sample size was 23,763. Within each study and 2 each ethnicity, measured fibrinogen levels were adjusted for age, sex, study-specific 3 covariates, and the residuals were rank normalized and rescaled by multiplying by the 4 original standard deviation, so that the transformed phenotype data have the same variances 
RESULTS
22
Simulation studies SMMAT-E at significance levels of 0.05, 0.0001, and 2.5 × 10 -6 , in the variant set analyses 2 of continuous and binary traits in single-cohort simulation studies. All 4 tests have well-3 controlled type I error rates at these significance levels, suggesting that GLMMs can be 4 effective in adjusting for population structure and cryptic relatedness in complex study 5 samples. This is also consistent with the quantile-quantile (QQ) plots in Figure 2 , which 6 show neither inflation nor deflation in the tail. SMMAT-E assuming all studies in the same group (hom) or in 4 separate groups (het) in 10 meta-analyses for combining 4 types of studies: with and without confounding by 11 population structure, with and without cryptic relatedness. We note that SMMAT-B 12 statistic has the same form in these two meta-analysis strategies, 24 therefore, we Figures 4 and 5 present the empirical power for causal variant sets at the significance level 21 of 2.5 × 10 -6 for continuous and binary traits, respectively. The power increases with the from 100%, 80% to 50% in each row, the power drops for all tests, but most substantially 1 for the burden test SMMAT-B. When the sample size is large (i.e., 10,000 samples),
2
SMMAT-E has the highest power, for both continuous and binary traits in all 9 simulation 3 scenarios. 6A) shows that all 4 tests have well-calibrated tail probabilities. 
Note that ̃= 1 for binary traits. Moreover, since the true value of 0 is small, assuming Therefore, The authors declare no competing interests. Ames, D.C., Carroll, A., Conomos, M.P., Gabriel, S. et al. (2017) . Analysis commons, a 30 team approach to discovery in a big-data environment for genetic epidemiology. Nat.
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Genet. 49, 1560-1563. The total sample size was 10,000, and results from 4,000 simulation replicates were 4 combined to get 40 million genetic variant sets.
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Continuous Traits Binary Traits Level 0.05 0.0001 2.5 × 10 -6 0.05 0.0001 2.5 × 10 -6 SMMAT-B 0.047 8.7 × 10 -5 2.0 × 10 -6 0.049 9.6 × 10 -5 2.0 × 10 -6 SMMAT-S 0.048 8.7 × 10 -5 2.0 × 10 -6 0.049 9.5 × 10 -5 2.3 × 10 -6 SMMAT-O 0.050 1.1 × 10 -4 3.0 × 10 -6 0.052 1.2 × 10 -4 3.0 × 10 -6 SMMAT-E 0.050 1.0 × 10 -4 3.0 × 10 -6 0.050 9.9 × 10 -5 2.0 × 10 -6 6 7 separate groups (het), in meta-analysis simulation studies at significance levels of 0.05, 10 0.0001, and 2.5 × 10 -6 . The total sample size was 12,000 from 12 studies, and results from 11 4,000 simulation replicates were combined to get 40 million genetic variant sets.
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Continuous Traits Binary Traits Level 0.05 0.0001 2.5 × 10 -6 0.05 0.0001 2.5 × 10 -6 SMMAT-B 0.051 1.0 × 10 -4 2.6 × 10 -6 0.051 1.1 × 10 -4 2.5 × 10 -6 Hom SMMAT-S 0.051 1.0 × 10 -4 2.6 × 10 -6 0.051 1.1 × 10 -4 2.1 × 10 -6 Het SMMAT-S 0.051 1.0 × 10 -4 2.8 × 10 -6 0.052 1.0 × 10 -4 2.4 × 10 -6 Hom SMMAT-O 0.053 1.3 × 10 -4 4.0 × 10 -6 0.053 1.4 × 10 -4 3.4 × 10 -6 Het SMMAT-O 0.052 1.1 × 10 -4 2.6 × 10 -6 0.052 1.1 × 10 -4 2.2 × 10 -6 Hom SMMAT-E 0.051 1.0 × 10 -4 2.5 × 10 -6 0.051 1.1 × 10 -4 2.6 × 10 -6 Het SMMAT-E 0.051 1.0 × 10 -4 2.8 × 10 -6 0.052 1.1 × 10 -4 3.0 × 10 -6 No. of variants SMMAT-B SMMAT-S SMMAT-O SMMAT-E 154,554 154,558 348 6.9 × 10 -5 1.6 × 10 -17 8.9 × 10 -17 6.2 × 10 -19 154,558 154,562 370 0.078 3.7 × 10 -11 2.4 × 10 -10 3.7 × 10 -14 154,562 154,566 326 0.76 1.5 × 10 -9 3.5 × 10 -9 4.2 × 10 -10 154,566 154,570 309 1.6 × 10 -8 9.7 × 10 -17 3.3 × 10 -16 3.1 × 10 -17 154,570 154,574 332 0.030 1.9 × 10 -7 5.2 × 10 -7 8.9 × 10 -8 154,574 154,578 349 2.1 × 10 -7 7.3 × 10 -7 2.8 × 10 -7 4.1 × 10 -13 154,578 154,582 342 1.7 × 10 -4 2.7 × 10 -5 2.8 × 10 -5 2.1 × 10 -9 5 6 Table 4 . CPU time in the TOPMed fibrinogen level SMMAT using summary statistics 7 from a sliding window analysis using non-overlapping 4 kb windows on chromosome 4 (n 8 = 23,763). Tests were performed using the GMMAT App (version 0.9.2) with one single 9 thread on a computing node with 15 GB total memory in the Analysis Commons. 
